APP and Alzheimer disease: Aβ antibody that binds and sequesters the Aβ peptides was able to prevent the increase in the total tau levels in APP V717I neurons, suggesting a crosstalk between the amyloid cascade and tau hyperphosphorylation in the AD brains [85].